BioSpace News Archive

As part of its Cradle to Career initiative, the Alexander Graham Bell Association for the Deaf and Hard of Hearing (AG Bell) launched Listen-Learn-Link, its international new parent hotline for parents, caregivers and guardians of children with hearing loss.

The American Heart Association/American Stroke Association has announced a statewide commitment of $6.5 million for its Mission: Lifeline Stroke initiative to expand and enhance stroke care in Nebraska.

Very Low Nicotine Content will eliminate all cigarettes’ ability to create and sustain addiction.

CerSci Therapeutics, a non-opioid drug development firm based in Dallas, Texas has received notice from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) that it has been awarded a Phase I Small Business Technology Transfer (STTR) grant totaling over $220,000. These funds will support the preclinical development of novel, proprietary small-molecules for the treatment of migraine.

InveniasPartners, a leading health care executive search and talent advisory services firm, is pleased to announce that Joseph E. Fournier, JD, MHA has joined the firm as a Partner.

Atrium Health’s President and CEO, Gene Woods, has been honored as one of 2018’s 100 Most Influential People in Healthcare by Modern Healthcare, being named in the top 25 of the most significant innovators, trailblazers and thought-leaders across the healthcare field

Systech, a global technology leader in consumer safety, brand protection, and product authentication, along with representatives from leading healthcare industry companies and associations, came together to explore the use of blockchain technology to support Drug Supply Chain Security Act (DSCSA) compliance.

OncLive®, the leading digital provider of resources and information to oncology professionals, will host the latest State of the Science Summit™ on the treatment of hematologic malignancies.

Cherie from Laser Rejuvenation by Cherie at ACA is pleased to announce that she has just posted an informative blog and video that answer a common question about radio frequency skin tightening.

FSD Pharma Inc. (“FSD Pharma”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), announced today the launch of a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”)